Amedeo's Top 20

Amedeo Smart

Independent Medical Education


03 September 2012

Multidisciplinary Journal Club

  1. Ordas I , Eckmann L, Talamini M, Baumgart DC, et al.
    Ulcerative colitis.
    Lancet 2012.

  1. Afdhal NH , Giannini EG, Tayyab G, Mohsin A, et al.
    Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    N Engl J Med 2012;367:716-24.

  2. Siegal D , Yudin J, Kaatz S, Douketis JD, et al.
    Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates.
    Circulation 2012.

  3. Friedberg JW , Byrtek M, Link BK, Flowers C, et al.
    Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study.
    J Clin Oncol 2012.

  4. Boissy AR , Ford PJ.
    A touch of MS: therapeutic mislabeling.
    Neurology 2012;78:1981-5.

  1. Smith BD , Morgan RL, Beckett GA, Falck-Ytter Y, et al.
    Hepatitis C Virus Testing of Persons Born During 1945 to 1965: Recommendations From the Centers for Disease Control and Prevention.
    Ann Intern Med 2012.

  2. Janne PA , Wang X, Socinski MA, Crawford J, et al.
    Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.
    J Clin Oncol 2012;30:2063-9.

  3. Pavord ID , Korn S, Howarth P, Bleecker ER, et al.
    Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
    Lancet 2012;380:651-9.

  4. Wong C , Jayaram L, Karalus N, Eaton T, et al.
    Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Lancet 2012;380:660-7.

  5. Hellwig S , Amtage F, Kreft A, Buchert R, et al.
    [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Neurology 2012.

  1. McCrindle BW .
    Familial hypercholesterolemia in children and adolescents.
    Curr Opin Lipidol 2012.

  2. Browne SK , Burbelo PD, Chetchotisakd P, Suputtamongkol Y, et al.
    Adult-onset immunodeficiency in Thailand and Taiwan.
    N Engl J Med 2012;367:725-34.

  3. Aghajanian C , Blank SV, Goff BA, Judson PL, et al.
    OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
    J Clin Oncol 2012;30:2039-45.

  4. Thanassoulis G , Lyass A, Benjamin EJ, Larson MG, et al.
    Relations of Exercise Blood Pressure Response to Cardiovascular Risk Factors and Vascular Function in the Framingham Heart Study.
    Circulation 2012.

  5. Gierach GL , Ichikawa L, Kerlikowske K, Brinton LA, et al.
    Relationship between mammographic density and breast cancer death in the breast cancer surveillance consortium.
    J Natl Cancer Inst 2012;104:1218-27.

  1. Carlsson LM , Peltonen M, Ahlin S, Anveden A, et al.
    Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects.
    N Engl J Med 2012;367:695-704.

  2. Bertagna F , Treglia G, Piccardo A, Giubbini R, et al.
    Diagnostic and Clinical Significance of F-18-FDG-PET/CT Thyroid Incidentalomas.
    J Clin Endocrinol Metab 2012.

  3. Aletaha D , Alasti F, Smolen JS.
    Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients.
    Ann Rheum Dis 2012.

  4. Halim SA , Newby LK.
    Review: Omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease.
    Ann Intern Med 2012;157:JC2-3.

  5. Zhu Y , Xiong M.
    Family-based association studies for next-generation sequencing.
    Am J Hum Genet 2012;90:1028-45.


more..


Privacy Policy